The worth of the drugmaker Novo Nordisk has shot up by greater than £6.5bn after analysis confirmed its new anti-obesity capsule resulted in nearly as a lot weight reduction as its Wegovy jab, because it races in opposition to its US rival Eli Lilly to get a pill therapy to market.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
.png?trim=0%2C0%2C0%2C0&width=1200&height=800&crop=1200%3A800&ssl=1 "Vote in our Unbiased Cash ballot: Which describes your present pension place greatest?")
